Athmic Biotech Solutions Pvt Ltd

📢 Exciting News! Meet the Athmic Biotech Chennai team at Startup Chennai - Seiga Pudhumai, a landmark event happening on November 12, 2024, at the D7 Auditorium, IITM Research Park, Chennai! Whether you’re exploring investment opportunities, considering a career in biotech, or interested in collaborative research, our team is excited to connect and discuss the future of biotech innovation. Athmic Biotech offers a range of R&D services and contract research services tailored to support industries in sectors such as healthcare, pharmaceuticals, and cosmetics. Let’s discuss how our capabilities can drive innovation and growth. 📩 To schedule an appointment, contact: mail@athmicbiotech.com #AthmicBiotech #StartupChennai #IITMResearchPark #BiotechInnovation #InvestmentOpportunities #CareerInBiotech #ResearchCollaborations #ContractResearch #R&D

⚡️ ‘Fast-Track Anti-Inflammatory Discovery Support by Athmic Biotech R&D Lab’🧪 🖌️Chronic inflammation is a major contributor to many diseases. Finding new anti-inflammatory treatments is crucial, and in-vitro biological studies offer a powerful tool to fast-track this discovery process. When it comes to discovering new anti-inflammatory treatments, understanding how cells respond to inflammation at the genetic level is key. COX (cyclooxygenase) and LOX (lipoxygenase) are two key pathways that spark our body’s response to injury and infection. By studying the expression patterns of these genes in cell culture, one can quickly evaluate the potential of new compounds to reduce inflammation. ℹ️What are COX and LOX? COX and LOX are inflammation’s messengers. COX-2, for instance, drives the production of prostaglandins, which signal pain and swelling. Meanwhile, LOX generates leukotrienes, triggering immune responses. Together, these pathways act as biomarkers to tell us if a compound can effectively induce/reduce inflammation. ℹ️How do we study it? To mimic inflammation, we start by treating cultured cells with an inflammatory agent like LPS (Lipopolysaccharide), which activates COX and LOX just as they would in the body. Then, using q-RT-PCR, we measure the gene expression levels, setting a baseline of activity. 🔗Here’s the exciting part—when we add an anti-inflammatory compound, we can directly observe if it reduces COX or LOX expression. A drop in these markers suggests the compound has real potential to calm inflammation. Significance 🔔. Rapid Screening: Biochemical assays allow us to test multiple compounds quickly, saving time and resources. 🔔 . Mechanistic Insights: Tracking COX and LOX activity using cell culture studies reveal not only if a compound works, but how it interacts with inflammation pathways. However, this would require additional experimentations at molecular level. 🔔. Precision Targeting: Compounds that reduce COX-2 or LOX gene expressions could be prime candidates for treating inflammation-related diseases such as arthritis or asthma. For research scholars and companies, studying COX and LOX in cell culture is a streamlined, effective way to gauge anti-inflammatory potential. This approach accelerates the journey from lab to treatment, providing us with the crucial data to fuel the development of more targeted therapies. 📣If you're a researcher working in this field, consider incorporating cell culture studies in combination with molecular expressions and biochemical assays into your workflow to gain valuable insights into the mechanisms of inflammation and identify promising drug candidates. For further assistance contact 📧mail@athmicbiotech.com 🌐 www.athmicbiotech.com 📞 +91 884-8185240 (WhatsApp) #pharma #biotechnology #research #inflammation #antiinflammatory #cellculture #drugdiscovery #COX2 #scienceforpublic #askthescientist

🔬 invitro Breast cancer Research Collaboration Opportunity at Athmic Biotech R&D Lab! In honor of 'Breast Cancer Awareness Month (BCAM)' this October 2024, we are advancing research on 'MCF-7' and 'MDA-MB-231' cell lines. We invite industry and academic institutions to collaborate on impactful projects in breast cancer research.  📊 Our Offerings:   - Collaborative research opportunities with industries and universities   - Gene expression studies by qRT-PCR and Western blotting   - Fluorescent microscopy studies in breast cancer cell lines   - Phase-contrast microscopy insights into breast cancer cell lines   - Relevant analysis services for academic scholars at nominal rates  Let's join hands to foster innovation and contribute meaningfully to breast cancer research. Together, we can make a difference!  Feel free to connect for collaboration opportunities.  #BreastCancerAwarenessMonth #BCAM #BreastCancerResearch #MCF7 #MDAMB231 #qRTPCR #WesternBlotting #FluorescentMicroscopy #ResearchCollaboration #AthmicBiotech #BiotechResearch

We are actively #hiring! Know anyone who might be interested?

Department of Environmental Sciences, University of Kerala, in association with Centre of Excellence in Microbiome (CoEM), Estuarine & Coastal Sciences Association, & Athmic Biotech Solutions is organizing a National Workshop on Microbiome of Coastal Environment (NWMCE 2024) on 19-22 November. Please see the link https://lnkd.in/dKX49wqh #NWMCE2024 #CoEM #CoastalMicrobiome #SERBGovtofIndia

“Delighted to host our esteemed clients, Anil K Dilwali Sir, Dr. Ranjana Gupta Ma’am (Retd. IIT Delhi), and Swamiji, at Athmic Biotech’s R&D facility 🧪🧫 Transparency and collaboration are key to our scientific journey, and visits like these inspire us to push boundaries. These veterans, working with a great vision, have been utilizing our in vitro contract research services for the past few months. We anticipate this direct visit will be a milestone in our shared research journey. Their motivational words will forever shine not only in our visitors’ book but also in our hearts. Grateful for the insightful discussions and their valuable time traveling all the way from Gurugram, Haryana!” At Athmic Biotech Solutions Pvt Ltd With Team Athmic Austin P, Dr.Nimisha Nair, Dr RAMYA KRISHNAN, Dr Viji Chandran

💡 Did you know? The key bioactive compounds in Bacopa monnieri are bacosides, specifically bacoside A and bacoside B. These compounds are renowned for their cognitive-enhancing, neuroprotective, and antioxidant properties: Bacoside A is primarily linked to improving memory and repairing damaged neurons. Bacoside B supports brain function and contributes to the plant’s therapeutic effects. 🌿 Well-Rooted Brahmi Tissue Culture Plants Available for Research! 🌿 We are excited to offer well-rooted Brahmi (Bacopa monnieri) plants cultured in tissue culture bottles, now available at Plant Tissue culture lab, Athmic Biotech R&D wing. If you're involved in research on neurobiology, phytochemistry, or medicinal plant applications, our Brahmi plants are a perfect resource for your studies. If you’re exploring the potential of Brahmi in your research, contact us for more details! #ResearchPlants #TissueCulture #BrahmiPlant #Bacosides #Neurobiology #Pharmacology #BiotechResearch #PlantScience #CognitiveEnhancement #AthmicBiotech

"An initiative by the R&D wing of Athmic Biotech Solutions Pvt Ltd, focused on upskilling postgraduate and research scholars. ‘A two-day advanced workshop on Animal Cell Culture Techniques and Applications’ was held at Malankara Catholic College, Mariagiri, in the Biotechnology Department on September 30 and October 1. Dr.Nimisha Nair R&D Director at Athmic Biotech, delivered an introductory talk on 'Animal Cell Culture: From Fundamentals to Biomedical Applications.' Dr. RAMYA KRISHNAN, Scientific Officer of the Molecular Biology Division at Athmic Biotech, presented 'Advanced Techniques in Molecular Biology.' Dr. Vijichandran, Scientific Officer of the Cell Culture Division at Athmic Biotech, led the team, including Divya Nair and Bella, who expertly conducted the animal cell culture practical sessions." If your institute is interested in collaborating with us, feel free to contact us and join in this upskilling effort. Contact us mail@athmicbiotech.com